StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.08−0.91 (-18.24%)

Close on Nov 18, 2026Market cap $400.20MP/E –Yield –

aTYR PHARMA market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

aTYR PHARMA's market cap was $16.60M on Nov 11, 2026, against $76.48M a year earlier. Over the last 5 years it ranged from $743.01K to $499.65M, with a median of $96.20M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$16.60M+765.4%
2025Dec 31, 2025$1.92M-99.3%
2024Dec 31, 2024$274.44M+232.4%
2023Dec 29, 2023$82.57M+30.0%
2022Dec 30, 2022$63.53M-69.4%
2021Dec 31, 2021$207.60M+435.5%
2020Dec 31, 2020$38.76M+139.0%
2019Dec 31, 2019$16.22M+8.6%
2018Dec 31, 2018$14.93M-85.6%
2017Dec 29, 2017$104.00M+104.0%
2016Dec 30, 2016$50.99M-78.1%
2015Dec 31, 2015$232.37M–

More aTYR PHARMA figures

See a number that looks wrong?